Skip to main content
Veterinary Medicines

CANGLOB DHLaPPi

Authorised
  • Immunoglobulins against Canine distemper virus, Canine
  • Immunoglobulins against Canine adenovirus 2, Canine
  • Immunoglobulins against Canine parvovirus, Canine
  • Immunoglobulins against Canine parainfluenza virus, Canine

Product identification

Medicine name:
CANGLOB DHLaPPi
Active substance:
  • Immunoglobulins against Canine distemper virus, Canine
  • Immunoglobulins against Canine adenovirus 2, Canine
  • Immunoglobulins against Canine parvovirus, Canine
  • Immunoglobulins against Canine parainfluenza virus, Canine
Target species:
  • Dog
Route of administration:
  • Intravenous use
  • Subcutaneous use
  • Intravenous use

Product details

Active substance and strength:
  • Immunoglobulins against Canine distemper virus, Canine
    160.00
    log10 virus neutralising unit(s)
    /
    1.00
    millilitre(s)
  • Immunoglobulins against Canine adenovirus 2, Canine
    160.00
    log10 virus neutralising unit(s)
    /
    1.00
    millilitre(s)
  • Immunoglobulins against Canine parvovirus, Canine
  • Immunoglobulins against Canine parainfluenza virus, Canine
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Dog
  • Subcutaneous use
    • Dog
  • Intravenous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AM
Authorisation status:
  • Valid
Authorised in:
  • Romania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Dyntec spol. s r.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Dyntec spol. s r.o.
Responsible authority:
  • Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
  • 130079
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Romanian (PDF)
Published on: 18/01/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."